Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)First-in-Human Study of Orally Administered GS-441524 for COVID-19
- First Posted Date
- 2021-04-26
- Last Posted Date
- 2021-08-10
- Lead Sponsor
- Copycat Sciences LLC
- Target Recruit Count
- 1
- Registration Number
- NCT04859244
- Locations
- 🇺🇸
Copycat Sciences Study Site, Houston, Texas, United States
News
No news found